Intrepid Family Office LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Intrepid Family Office LLC reported 33 stock positions worth $94.8 million. Its top holding was VG Morningstar TS MKT ETF-US (VTI) at 33.6% of the portfolio, followed by Shell PLC-ADR (SHEL, 6.6%) and Adams Diversified Equity (ADX, 5.4%).
- Most Recent 13F
- Q2 2026
- Location
- SARASOTA, FL
- CIK
- 0001596197
- Portfolio Value
- $94.8M (Q4 2024)
- SEC Filing
- 0001013594-25-000277 ↗ filed Feb 14, 2025
Holdings Value
Holdings 33 stocks · $94.8M
| VTI VG Morningstar TS MKT ETF-US | 33.62% | 110,000 | $31.9M | — |
| SHEL Shell PLC-ADR | 6.61% | 100,000 | $6.3M | — |
| ADX Adams Diversified Equity | 5.36% | 251,746 | $5.1M | — |
| MDT Medtronic PLC | 5.05% | 60,000 | $4.8M | — |
| PEO Adams Natural Resources Fund | 4.31% | 188,221 | $4.1M | — |
| NXPI NXP Semiconductors NV | 4.27% | 19,500 | $4.1M | — |
| SLRC SLR Investment Corp. | 3.94% | 231,400 | $3.7M | — |
| INFL Horizon Kinetics Infl Benef | 3.41% | 85,000 | $3.2M | — |
| IGV iShares Expanded Tech-Softwa | 3.17% | 30,000 | $3.0M | — |
| INDA iShares MSCI India ETF | 2.78% | 50,000 | $2.6M | — |
| OEC Orion SA | 2.75% | 165,000 | $2.6M | — |
| BSTZ BlackRock Sci & Tech TRM TR | 2.27% | 104,174 | $2.2M | — |
| MSFT Microsoft Corp. | 2.22% | 5,000 | $2.1M | — |
| ASML ASML Holding NV-NY Reg SHS | 2.01% | 2,750 | $1.9M | — |
| PFE Pfizer Inc. | 1.82% | 65,000 | $1.7M | — |
| ICSH iShares Ultra Short Duration | 1.73% | 32,500 | $1.6M | — |
| NTRA Natera Inc. | 1.50% | 9,000 | $1.4M | — |
| SIVR Abrdn Physical Silver Shares | 1.45% | 50,000 | $1.4M | — |
| PPLT Abrdn Physical Platinum SHRS | 1.43% | 16,354 | $1.4M | — |
| LSAK Lesaka Technologies Inc. | 1.37% | 237,896 | $1.3M | — |
| SCUS Schwab Ultra-Short Inc. ETF | 1.32% | 50,000 | $1.3M | — |
| GSY Invesco Ultra Short Duration | 1.32% | 25,000 | $1.3M | — |
| VUSB Vanguard Ultra Short Bond Et | 1.31% | 25,000 | $1.2M | — |
| JPST JPMorgan Ultra-Short Income | 1.20% | 22,500 | $1.1M | — |
| PULS Pgim Ultra Short Bond ETF | 1.18% | 22,500 | $1.1M | — |
| WY Weyerhaeuser Co. | 0.89% | 30,000 | $845K | — |
| NSLR Neostellar Capital Corp. filed as SURO CAPITAL CORP | 0.62% | 100,000 | $588K | — |
| ORGO Organogenesis Holdings Inc. | 0.35% | 105,000 | $336K | — |
| BHP BHP Group Ltd.-Spon ADR | 0.26% | 5,000 | $244K | — |
| IOVA Iovance Biotherapeutics Inc. | 0.23% | 30,000 | $222K | — |
| CCCC C4 Therapeutics Inc. | 0.15% | 40,000 | $144K | — |
| FOCL Edap TMS SA -ADR | 0.06% | 25,000 | $55K | — |
| FLNA Filana Therapeutics Inc. filed as CASSAVA SCIENCES INC | 0.02% | 10,000 | $24K | — |
Options reported separately and not counted above: IWM calls ($1.1M), CCCC calls ($36K).
Portfolio Sells Q4 2024
No earlier filing to compare with.
Portfolio Buys Q4 2024
No earlier filing to compare with.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 34 | $108.5M | VTI, GLD, ADX, NXPI, ASML |
| Q1 2026 | 37 | $115.0M | GLD, VTI, PPLT, GDXJ, ADX |
| Q4 2025 | 36 | $103.9M | GLD, VTI, PPLT, ADX, GDXJ |
| Q3 2025 | 36 | $110.6M | VTI, GLD, PPLT, SPY, ADX |
| Q2 2025 | 37 | $92.6M | GLD, VTI, PPLT, ADX, GDXJ |
| Q1 2025 | 30 | $67.2M | VTI, SHEL, ADX, PEO, SLRC |
| Q4 2024 | 33 | $94.8M | VTI, SHEL, ADX, MDT, PEO |